Product or Service

China artemisinin

Profile:Other|Ref:PSL217517YH | Country: Chine | Currency: | Export: No


Currency :
incoterm : fob
country : China
DESCRIPTION

synonyms: arteannuin; artemisine; qinghaosu; artemisia annua extract origin:aerial parts of artemisia annua
chemical name: 3r,5as,6r,8as,9r,12s,12ar)-octahydro-3,6,9-trimethyl-3,12-epoxy-12h-pyrano[4. 3-j]-1,2-benzodioxepin-10(3h)-one.
appearance: white needle crystal.
specification: artemisinin 99% hplc
test method: hplc.
solubility: soluble in ethanol and hexane.
characteristic: 100% natural, and it's gmo free, and is not irradiated.
cas#: 63968-64-9.
molecular formula: c15h22o5
molecular weight: 282. 3
description: artemisinin, also known as qinghaosu, is isolated from the dry leaves of arteisia annua ("sweet wormwood"). This plant has to be grown each year stating from seeds. The plant is peculiar in its behaviour. Nicely grown-up plants may be devoid of artemisinin. In order that this product is synthetised by the plant special agricultural and climatological conditions must be respected. The plant can grow in many places but it may not contain artemisinin.
function:
1. Antimalarial;
2. Restrain plasmodium growth and directly kill plasmodium;
3. Anti-inflammatory and cancer;
4. Relieve cough and asthma;
5. Reduce blood pressure, allay a fever and restrain a dermatophyte.
according to over 2000 clinical case studies, when used for the treatment of tertian fever, it is better than chloroquine in terms of time to suppress the pathogen. No adverse effect in clinical cases. Esp. Useful for the treatment of cases resistant to chloroquine. However, the short term recurrance rate is higher than chloroquine.
dosage:according to large amount of clinical study, for the treatment of malaria, use intramuscular injections of 0. 3g each time each day for three days, for a total amount of 0. 9-1. 2g; double first dose for severe case.
packing detail:packed in paper-drums and two plastic-bags inside. Net weight:25kgs/drum.

Information Stock : Product in stock

Attachment


No attachments


Contact the company
intermediation